Novavax, Inc.
MX ˙ BMV ˙ US6700024010
SecurityMX:NVAX / Novavax, Inc.
InstitutionAllianz Asset Management GmbH
Latest Disclosed Ownership1,859,854 shares
Latest Disclosed Value $ 15,139,212
Allianz Asset Management GmbH reports 19.98% decrease in ownership of NVAX / Novavax, Inc.

On May 11, 2026 - Allianz Asset Management GmbH filed a 13F-HR form disclosing ownership of 1,859,854 shares of Novavax, Inc. (MX:NVAX) valued at $15,139,212 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 2,324,142 shares of Novavax, Inc.. This represents a change in shares of -19.98% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F NOVAVAX COM NEW 670002401 1,859,854 -464,288 -19.98 15,139 -3.07 0.0159
2026-02-11 2025-12-31 13F NOVAVAX COM NEW 670002401 2,324,142 914,408 64.86 15,618 27.79 0.0158
2025-11-04 2025-09-30 13F NOVAVAX COM NEW 670002401 1,409,734 872,987 162.64 12,222 261.49 0.0136
2025-07-28 2025-06-30 13F NOVAVAX COM NEW 670002401 536,747 536,747 3,382 0.0040
2024-08-13 2024-06-30 13F NOVAVAX COM NEW 670002401 0 -1,469,633 -100.00 0 -100.00
2024-05-14 2024-03-31 13F NOVAVAX COM NEW 670002401 1,469,633 834,941 131.55 7,025 130.60 0.0108
2024-02-12 2023-12-31 13F NOVAVAX COM NEW 670002401 634,692 199,771 45.93 3,047 -3.24 0.0050
2023-11-13 2023-09-30 13F NOVAVAX COM NEW 670002401 434,921 40,669 10.32 3,149 7.48 0.0053
2023-08-14 2023-06-30 13F NOVAVAX COM NEW 670002401 394,252 394,252 2,929 0.0052
2022-11-08 2022-09-30 13F NOVAVAX COM NEW 670002401 0 -29,882 -100.00 0 -100.00
2022-08-12 2022-06-30 13F NOVAVAX COM NEW 670002401 29,882 -41,980 -58.42 1,537 -70.96 0.0015
2022-05-13 2022-03-31 13F NOVAVAX COM NEW 670002401 71,862 50,708 239.71 5,292 73.05 0.0039
2022-02-11 2021-12-31 13F NOVAVAX COM NEW 670002401 21,154 -116,470 -84.63 3,058 -89.28 0.0021
2021-11-10 2021-09-30 13F NOVAVAX COM NEW 670002401 137,624 88,058 177.66 28,532 171.14 0.0222
2021-08-16 2021-06-30 13F NOVAVAX COM NEW 670002401 49,566 -32,095 -39.30 10,523 -28.93 0.0090
2021-05-13 2021-03-31 13F NOVAVAX COM NEW 670002401 81,661 57,617 239.63 14,806 452.26 0.0144
2021-02-16 2020-12-31 13F NOVAVAX COM NEW 670002401 24,044 20,882 660.40 2,681 681.63 0.0026
2020-11-13 2020-09-30 13F NOVAVAX COM NEW 670002401 3,162 3,162 343 0.0004
2019-08-08 2019-06-30 13F NOVAVAX COM 670002104 0 -16,916 -100.00 0 -100.00
2019-05-13 2019-03-31 13F NOVAVAX COM 670002104 16,916 6,468 61.91 9 -52.63 0.0000
2019-04-02 2018-12-31 13F/A-1 NOVAVAX COM 670002104 10,448 10,448 19 0.0000
2019-02-13 2018-12-31 13F NOVAVAX COM 670002104 10,448 10,448 19
2019-04-09 2018-09-30 13F/A-1 NOVAVAX COM 670002104 0 -444,150 -100.00 0 -100.00
2019-04-09 2018-06-30 13F/A-1 NOVAVAX COM 670002104 444,150 8,395 1.93 595 -34.97 0.0006
2018-08-13 2018-06-30 13F NOVAVAX COM 670002104 444,150 8,395 595
2019-04-09 2018-03-31 13F/A-2 NOVAVAX COM 670002104 435,755 435,755 0.00 915 0.00 0.0009
2018-05-23 2018-03-31 13F/A-1 NOVAVAX COM 670002104 435,755 0 915 0.0009
2018-05-14 2018-03-31 13F NOVAVAX COM 670002104 435,755 435,755 915
2019-04-17 2016-09-30 13F/A-1 NOVAVAX COM 670002104 0 -595,806 -100.00 0 -100.00
2017-01-24 2016-06-30 13F/A-1 NOVAVAX COM 670002104 595,806 208,071 53.66 4,332 116.49 0.0046
2016-08-12 2016-06-30 13F NOVAVAX COM 670002104 595,806 4,332
2016-05-13 2016-03-31 13F NOVAVAX COM 670002104 387,735 4,825 1.26 2,001 -37.51 0.0023
2017-01-24 2015-12-31 13F/A-1 NOVAVAX COM 670002104 382,910 -750 -0.20 3,202 18.02 0.0036
2016-02-16 2015-12-31 13F NOVAVAX COM 670002104 382,910 3,202
2017-01-24 2015-09-30 13F/A-2 NOVAVAX COM 670002104 383,660 750 0.20 2,713 -36.39 0.0032
2015-11-20 2015-09-30 13F/A-1 NOVAVAX COM 670002104 383,660 0 2,713 0.0028
2015-11-13 2015-09-30 13F NOVAVAX COM 670002104 383,660 2,713
2015-09-22 2015-06-30 13F/A-1 NOVAVAX COM 670002104 382,910 -8,560 -2.19 4,265 31.76 0.0046
2015-08-14 2015-06-30 13F NOVAVAX COM 670002104 382,910 4,265
2017-01-24 2015-03-31 13F/A-1 NOVAVAX COM 670002104 391,470 168,235 75.36 3,237 144.49 0.0037
2015-05-15 2015-03-31 13F NOVAVAX COM 670002104 391,470 3,237,456
2015-02-17 2014-12-31 13F NOVAVAX COM 670002104 223,235 223,235 1,324 0.0015
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.